Meds & supplements › Lamotrigine
Medicine · Anti-epileptic Agent
Lamotrigine orally disintegrating tablets are indicated for: Epilepsy—adjunctive therapy in patients aged 2 years and older: partial-onset seizures.
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
WARNING: SERIOUS SKIN RASHES Lamotrigine can cause serious rashes requiring hospitalization and discontinuation of treatment. The incidence of these rashes, which have included Stevens-Johnson syndrome, is approximately 0.3% to 0.8% in pediatric patients (aged 2 to 17 years) and 0.08% to 0.3% in adults receiving lamotrigine. One rash-related death was reported in a prospectively followed cohort of 1,983 pediatric patients (aged 2 to 16 years) with epilepsy taking lamotrigine as adjunctive therapy. In worldwide postmarketing experience, rare cases of toxic epidermal necrolysis and/or rash-related death have been reported in adult and pediatric patients, but their numbers are too few to permit a precise estimate of the rate. In addition to age, factors that may increase the risk of occurrence or the severity of rash caused by lamotrigine include coadministration of lamotrigine with valproate (includes valproic acid and divalproex sodium), exceeding the recommended initial dose of lamotrigine, exceeding the recommended dose escalation for lamotrigine, or the presence of the HLA-B*1502 allele However, cases have occurred in the absence of these factors. Nearly all cases of life-threatening rashes caused by lamotrigine have occurred within 2 to 8 weeks of treatment initiation. However, isolated cases have occurred after prolonged treatment (e.g., 6 months). Accordingly, duration of therapy cannot be relied upon as means to predict the potential risk heralded by the first appearance of a rash. Although benign rashes are also caused by lamotrigine, it is not possible to predict reliably which rashes will prove to be serious or life threatening. Accordingly, lamotrigine should ordinarily be discontinued at the first sign of rash, unless the rash is clearly not drug related. Discontinuation of treatment may not prevent a rash from becoming life threatening or permanently disabling or disfiguring. WARNING: SERIOUS SKIN RASHES See full prescribing information for complete boxed warning. Cases of life-threatening serious rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis, and/or rash-related death have been caused by lamotrigine. The rate of serious rash is greater in pediatric patients than in adults. Additional factors that may increase the risk of rash include: coadministration with valproate. exceeding recommended initial dose of lamotrigine. exceeding recommended dose escalation for lamotrigine. presence of the HLA-B*1502 allele. Benign rashes are also caused by lamotrigine; however, it is not possible to predict which rashes will prove to be serious or life threatening. Lamotrigine should be discontinued at the first sign of rash, unless the rash is clearly not drug related.
Lamotrigine orally disintegrating tablets are indicated for: Epilepsy—adjunctive therapy in patients aged 2 years and older: partial-onset seizures. primary generalized tonic-clonic (PGTC) seizures. generalized seizures of Lennox-Gastaut syndrome. Epilepsy—monotherapy in patients aged 16 years and older: Conversion to monotherapy in patients with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug.
Bipolar disorder: Maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes in patients treated for acute mood episodes with standard therapy. Limitations of Use: Treatment of acute manic or mixed episodes is not recommended. Effectiveness of lamotrigine in the acute treatment of mood episodes has not been established.
1.1 Epilepsy Adjunctive Therapy Lamotrigine orally disintegrating tablets are indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older: partial-onset seizures. primary generalized tonic-clonic (PGTC) seizures. generalized seizures of Lennox-Gastaut syndrome. Monotherapy Lamotrigine orally disintegrating tablets are indicated for conversion to monotherapy in adults (aged 16 years and older) with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (AED).
Safety and effectiveness of lamotrigine orally disintegrating tablets have not been established as initial monotherapy; for conversion to monotherapy from AEDs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproate; or for simultaneous conversion to monotherapy from 2 or more concomitant AEDs. 1.2 Bipolar Disorder Lamotrigine orally disintegrating tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy.
Limitations of Use Treatment of acute manic or mixed episodes is not recommended. Effectiveness of lamotrigine orally disintegrating tablets in the acute treatment of mood episodes has not been established.
1. Lamotrigine orally disintegrating tablets may cause a serious skin rash that may cause you to be hospitalized or even cause death. There is no way to tell if a mild rash will become more serious. A serious skin rash can happen at any time during your treatment with lamotrigine orally disintegrating tablets, but is more likely to happen within the first 2 to 8 weeks of treatment.
Children and teenagers aged between 2 and 17 years have a higher chance of getting this serious skin rash while taking lamotrigine orally disintegrating tablets. The risk of getting a serious skin rash is higher if you: take lamotrigine orally disintegrating tablets while taking valproate [DEPAKENE (valproic acid) or DEPAKOTE (divalproex sodium)].
take a higher starting dose of lamotrigine orally disintegrating tablets than your healthcare provider prescribed. increase your dose of lamotrigine orally disintegrating tablets faster than prescribed. The risk of serious skin reactions may be associated with a variant in genes called HLA-B*1502 in people from Asian origin (mainly of Han Chinese and Thai origin).
See, “Before taking lamotrigine orally disintegrating tablets, tell your healthcare provider about all of your health conditions”. Call your healthcare provider right away if you have any of the following: a skin rash blistering or peeling of your skin hives painful sores in your mouth or around your eyes These symptoms may be the first signs of a serious skin reaction.
A healthcare provider should examine you to decide if you should continue taking lamotrigine orally disintegrating tablets. 2. Other serious reactions, including serious blood problems or liver problems. Lamotrigine orally disintegrating tablets can also cause other types of allergic reactions or serious problems that may affect organs and other parts of your body like your liver or blood cells.
You may or may not have a rash with these types of reactions. Call your healthcare provider right away if you have any of these symptoms: fever frequent infections severe muscle pain swelling of your face, eyes, lips, or tongue swollen lymph glands unusual bruising or bleeding, looking pale weakness, fatigue yellowing of your skin or the white part of your eyes trouble walking or seeing seizures for the first time or happening more often pain and/or tenderness in the area towards the top of your stomach (enlarged liver and/or spleen) 3.
In patients with known heart problems, the use of lamotrigine orally disintegrating tablets may lead to a fast heart beat. Call your healthcare provider right away if you: have a fast, slow, or pounding heart beat. feel your heart skip a beat. have shortness of breath. have chest pain. feel lightheaded. 4. Like other antiepileptic drugs, lamotrigine orally disintegrating tablets may cause suicidal thoughts or actions in a very small number of people, about 1 in 500.
Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying attempt to commit suicide new or worse depression new or worse anxiety feeling agitated or restless panic attacks trouble sleeping (insomnia) new or worse irritability acting aggressive, being angry, or violent acting on dangerous impulses an extreme increase in activity and talking (mania) other unusual changes in behavior or mood Do not stop lamotrigine orally disintegrating tablets without first talking to a healthcare provider.
Stopping lamotrigine orally disintegrating tablets suddenly can cause serious problems. Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare provider may check for other causes. How can I watch for early symptoms of suicidal thoughts and actions in myself or a family member?
Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. Keep all follow-up visits with your healthcare provider as schedul
Take lamotrigine orally disintegrating tablets exactly as prescribed. Your healthcare provider may change your dose. Do not change your dose without talking to your healthcare provider. Do not stop taking lamotrigine orally disintegrating tablets without talking to your healthcare provider. Stopping lamotrigine orally disintegrating tablets suddenly may cause serious problems.
For example, if you have epilepsy and you stop taking lamotrigine orally disintegrating tablets suddenly, you may have seizures that do not stop. Talk with your healthcare provider about how to stop lamotrigine orally disintegrating tablets slowly. If you miss a dose of lamotrigine orally disintegrating tablets, take it as soon as you remember.
If it is almost time for your next dose, just skip the missed dose. Take the next dose at your regular time. Do not take 2 doses at the same time. If you take too much lamotrigine orally disintegrating tablets, call your healthcare provider or your local Poison Control Center or go to the nearest hospital emergency room right away.
You may not feel the full effect of lamotrigine orally disintegrating tablets for several weeks. If you have epilepsy, tell your healthcare provider if your seizures get worse or if you have any new types of seizures. Lamotrigine ODT should be placed on the tongue and moved around the mouth. The tablet will rapidly disintegrate, can be swallowed with or without water, and can be taken with or without food.
If you receive lamotrigine orally disintegrating tablets in a blister pack, examine the blister pack before use. Do not use if blisters are torn, broken, or missing.
” 6. People prescribed lamotrigine orally disintegrating tablets have sometimes been given the wrong medicine because many medicines have names similar to lamotrigine orally disintegrating tablets, so always check that you receive lamotrigine orally disintegrating tablets. Taking the wrong medication can cause serious health problems.
When your healthcare provider gives you a prescription for lamotrigine orally disintegrating tablets: Make sure you can read it clearly. Talk to your pharmacist to check that you are given the correct medicine. Each time you fill your prescription, check the tablets you receive against the pictures of the tablets below.
These pictures show the distinct wording, colors, and shapes of the tablets that help to identify the right strength of lamotrigine orally disintegrating tablets. Immediately call your pharmacist if you receive a lamotrigine orally disintegrating tablet that does not look like one of the tablets shown below, as you may have received the wrong medication.
Lamotrigine orally disintegrating tablets What are lamotrigine orally disintegrating tablets? Lamotrigine orally disintegrating tablets are a prescription medicine used: together with other medicines to treat certain types of seizures (partial-onset seizures, primary generalized tonic-clonic seizures, generalized seizures of Lennox-Gastaut syndrome) in people aged 2 years and older.
alone when changing from 1 other medicine used to treat partial-onset seizures in people aged 16 years and older. for the long-term treatment of bipolar I disorder to lengthen the time between mood episodes in people who have been treated for mood episodes with other medicine. It is not known if lamotrigine orally disintegrating tablets are safe or effective in people younger than 18 years with mood episodes such as bipolar disorder or depression.
It is not known if lamotrigine orally disintegrating tablets are safe or effective when used alone as the first treatment of seizures. It is not known if lamotrigine orally disintegrating tablets are safe or effective for people with mood episodes who have not already been treated with other medicines. Lamotrigine orally disintegrating tablets should not be used for acute treatment of manic or mixed mood episodes.
Do not take Lamotrigine: if you have had an allergic reaction to lamotrigine or to any of the inactive ingredients in lamotrigine orally disintegrating tablets. See the end of this leaflet for a complete list of ingredients in lamotrigine orally disintegrating tablets. Before taking lamotrigine orally disintegrating tablets, tell your healthcare provider about all of your health conditions, including if you: have had a rash or allergic reaction to another antiseizure medicine.
are of Asian origin, have had HLA testing before, and know you are carrying the genetic variant, HLA-B*1502. have or have had depression, mood problems, or suicidal thoughts or behavior. have a history of heart problems or irregular heart beats or any of your family members have any heart problem, including genetic abnormalities.
have had aseptic meningitis after taking lamotrigine orally disintegrating tablets. are taking estrogen-containing products, including oral contraceptives (birth control pills) or other female hormonal medicines (such as hormone replacement therapy). Do not start or stop taking birth control pills or other female hormonal medicine until you have talked with your healthcare provider.
Tell your healthcare provider if you have any changes in your menstrual pattern such as breakthrough bleeding. Stopping these medicines while you are taking lamotrigine orally disintegrating tablets may cause side effects (such as dizziness, lack of coordination, or double vision). Starting these medicines may lessen how well lamotrigine orally disintegrating tablets works.
are pregnant or plan to become pregnant. It is not known if lamotrigine orally disintegrating tablets may harm your unborn baby. If you become pregnant while taking lamotrigine orally disintegrating tablets, talk to your healthcare provider about registering with the North American Antiepileptic Drug Pregnancy Registry.
You can enroll in this registry by calling 1-888-233-2334. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy. are breastfeeding. Lamotrigine passes into breast milk and may cause side effects in a breastfed baby. If you breastfeed while taking lamotrigine orally disintegrating tablets, watch your baby closely for trouble breathing, episodes of temporarily stopping breathing, sleepiness, or poor sucking.
Call your baby’s healthcare provider right away if you see any of these problems. Talk to your healthcare provider about the best way to feed your baby if you take lamotrigine orally disintegrating tablets. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Lamotrigine orally disintegrating tablets and certain other medicines may interact with each other. This may cause serious side effects. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
Do not drive, operate machinery, or do other dangerous activities until you know how lamotrigine orally disintegrating tablets affects you. What are the possible side effects of lamotrigine orally disintegrating tablets? Lamotrigine orally disintegrating tablets can cause serious side effects. Common side effects of lamotrigine orally disintegrating tablets include: dizziness tremor headache rash blurred or double vision fever lack of coordination abdominal pain infections, including seasonal flu sleepiness back pain nausea, vomiting diarrhea tiredness insomnia dry mouth stuffy nose sore throat These are not all the possible side effects of lamotrigine orally disintegrating tablets.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Store lamotrigine orally disintegrating tablets at room temperature between 20° to 25°C (68° to 77°F); with excursions permitted to 15° to 30°C (59° to 86°F).. Keep lamotrigine orally disintegrating tablets and all medicines out of the reach of children.
sofidex [Internet]. Daloreum; c2026. Lamotrigine; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/lamotrigine
sofidex. (2026, August 2). Lamotrigine. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/lamotrigine
Lamotrigine. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/lamotrigine
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.